Response to emerging infection leading to outbreak of linezolid-resistant enterococci.

Emerging Infectious Diseases
Marion A KainerWilliam Schaffner

Abstract

Linezolid was approved in 2000 for treatment of gram-positive coccal infections. We performed a case-control study during a hospital outbreak of linezolid-resistant enterococci (LRE) infections, comparing cases of LRE infection (cases) with linezolid-sensitive enterococci infections (controls). Nasal and perirectal swab samples were obtained from all patients in a 1-day point-prevalence survey. We examined antimicrobial drug use and calculated the defined daily dose of linezolid per 1,000 patient-days. Fifteen LRE cases were identified (13 Enterococcus faecalis and 2 E. faecium); 7 were vancomycin-resistant. Compared with controls, case-patients had increased in-hospital mortality rates and lengths of stay. Multivariate analysis identified independent predictors of LRE infection: prior cultures positive for methicillin-resistant Staphylococcus aureus (adjusted odds ratio [AOR] 27), hospitalization duration before index culture (AOR 1.1 per day), and duration of preceding linezolid therapy (AOR 1.1 per day). Linezolid exposure and patient-to-patient transmission appear to be responsible for LRE infections, an important emeraina hospital problem.

References

Mar 21, 1998·Archives of Internal Medicine·V StosorG A Noskin
Mar 27, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A D HarrisM H Samore
Apr 27, 2001·International Journal of Food Microbiology·L M Graves, B Swaminathan
Mar 2, 2002·The Lancet Infectious Diseases·M J BontenR A Weinstein
Mar 15, 2002·The New England Journal of Medicine·Inmaculada A HerreroRobin Patel
May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anthony D HarrisYehuda Carmeli
Oct 31, 2002·The Journal of Antimicrobial Chemotherapy·Cressida AucklandAlan P Johnson
Nov 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Manjunath P PaiJohn P Quinn
Nov 5, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A P JohnsonF J Allerberger
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sibtain RahimRobert A Press
Jun 6, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carlene A MutoUNKNOWN SHEA
Jun 7, 2003·International Journal of Antimicrobial Agents·M BassettiL M Dembry
Jul 13, 2004·The Pediatric Infectious Disease Journal·Steven C BuckinghamFred C Tenover
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Venkata G Meka, Howard S Gold
Feb 25, 2005·The Journal of Antimicrobial Chemotherapy·Chun-Hsing LiaoPo-Ren Hsueh
May 5, 2005·International Journal of Pediatric Otorhinolaryngology·Srikanth I NaiduJerome W Thompson
Dec 24, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I KlareW Witte
Feb 25, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M G BonoraR Fontana
May 5, 2006·Journal of Clinical Microbiology·Alexandre R MarraMichael B Edmond
Sep 7, 2006·Journal of Clinical Microbiology·Thomas E DobbsCraig J Hoesley
Sep 20, 2006·Antimicrobial Agents and Chemotherapy·Jamela SeedatHany Sahly
Dec 11, 2007·American Journal of Infection Control·Jane D SiegelUNKNOWN Healthcare Infection Control Practices Advisory Committee

❮ Previous
Next ❯

Citations

Apr 19, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B SaagerM A Horstkotte
Nov 26, 2010·Médecine sciences : M/S·Vincent Cattoir, Roland Leclercq
Mar 14, 2009·The Journal of Antimicrobial Chemotherapy·F Kate GouldUNKNOWN MRSA Working Party of the British Society for Antimicrobial Chemotherapy
Apr 26, 2012·The Journal of Antimicrobial Chemotherapy·Eleni NtokouSpyros Pournaras
Dec 5, 2012·The Journal of Antimicrobial Chemotherapy·Vincent Cattoir, Roland Leclercq
Jun 5, 2013·Antimicrobial Agents and Chemotherapy·Milena McLaughlinMarc H Scheetz
Aug 31, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Ana María Sánchez-DíazPatricia Ruiz-Garbajosa
May 31, 2014·Revista española de geriatría y gerontología·Juan González Del CastilloJosé Barberán
Feb 19, 2013·Enfermedades infecciosas y microbiología clínica·Miguel Sánchez-García, María Ángeles de la Torre-Ramos
Mar 1, 2012·American Journal of Infection Control·Jessina C McGregorDavid T Bearden
Feb 7, 2012·Enfermedades infecciosas y microbiología clínica·Emilia Cercenado
Apr 12, 2011·Medicina clínica·Emilia Cercenado
Sep 24, 2011·Advances in Medical Sciences·B Kowalska-KrochmalG Gościniak
Apr 19, 2011·International Journal of Antimicrobial Agents·Michael J Dowzicky, Eva Chmelařová
Feb 18, 2010·Diagnostic Microbiology and Infectious Disease·Douglas J BiedenbachRonald N Jones
Nov 17, 2009·Diagnostic Microbiology and Infectious Disease·David J FarrellRonald N Jones
Sep 1, 2009·Diagnostic Microbiology and Infectious Disease·Rosa Gómez-GilJesus Mingorance
Nov 22, 2008·Diagnostic Microbiology and Infectious Disease·Ronald N JonesRodrigo E Mendes
Jan 1, 2008·International Journal of Antimicrobial Agents·Evelina Tacconelli, Maria A Cataldo
Aug 18, 2016·Journal of Global Antimicrobial Resistance·Gladys Villas Boas do PradoSilvia F Costa
Jun 17, 2009·Journal of Medical Microbiology·Franca CianLucilla Dolzani
Jul 27, 2012·Scandinavian Journal of Infectious Diseases·Annarita MazzariolGiuseppe Cornaglia
Jul 4, 2012·Diagnostic Microbiology and Infectious Disease·Elena M SantayanaNina M Clark
May 20, 2009·Neonatal Network : NN·Susan Givens Bell
Jul 11, 2012·Interdisciplinary Perspectives on Infectious Diseases·S Sujatha, Ira Praharaj
Apr 2, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R Leclercq
Aug 16, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E-M KluppH Rohde
Nov 13, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Jason M PogueBrian A Potoski
May 20, 2009·The Pediatric Infectious Disease Journal·Maria G Lopez Marti, Ravi Jhaveri
Feb 10, 2018·Anais Da Academia Brasileira De Ciências·Géssica A CostaAmanda DE S DA Motta
Sep 17, 2015·Circulation·Larry M BaddourUNKNOWN American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular
Oct 14, 2008·Expert Review of Anti-infective Therapy·Natasha V D V Ratnaraja, Peter M Hawkey
Oct 14, 2008·Expert Review of Anti-infective Therapy·Cesar A Arias, Barbara E Murray
Feb 16, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I GawryszewskaE Sadowy

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Software Mentioned

SAS
Epi Info

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.